Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy

Cell Reports(2021)10.1016/j.celrep.2021.109578Source: DataRank Database

Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 80 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access80 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (40)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Emily Vucic ORCID,Emma Kurz ORCID,Cristina Hajdu ORCID,Dafna Bar‐Sagi ORCID,Despina Siolas ORCID

Live enrichment

PubMed:34433022

National Cancer Institute

Grant: CA210263

National Cancer Institute

Grant: K08CA241341

Lustgarten Foundation

Grant: SU2C-AACR-DT14-14

Canadian Institutes of Health Research

Grant: 146792

National Institutes of Health

Grant: P41 EB017183

Canadian Institutes of Health Research

Grant: unidentified

unidentified

NCI NIH HHS

Grant: F30 CA243205

NCI NIH HHS

Grant: P30 CA016087

NCI NIH HHS

Grant: R35 CA210263

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.celrep.2021.109578

publisherhttps://api.elsevier.com/content/article/PII:S2211124721010123?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721010123?httpAccept=text/plain

repositoryhttps://doaj.org/article/efbd7f57306b45f096d5b623f1b66789

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8687588

Fields of Study

0301 basic medicine03 medical and health sciencesAnimalsCarcinoma, Pancreatic DuctalGain of Function MutationImmunotherapyMiceMice, TransgenicNeutrophil InfiltrationNeutrophilsPancreatic NeoplasmsTh1 CellsTumor Suppressor Protein p53

MeSH Terms

AnimalsCarcinoma, Pancreatic DuctalGain of Function MutationImmunotherapyMiceMice, TransgenicNeutrophil InfiltrationNeutrophilsPancreatic NeoplasmsTh1 CellsTumor Suppressor Protein p53

Keywords

QH301-705.5Neutrophilspancreatic cancermutant p53immune microenvironmentMice, TransgenicTh1 CellsPancreatic NeoplasmsMiceNeutrophil InfiltrationGain of Function MutationAnimalsImmunotherapyBiology (General)Tumor Suppressor Protein p53Carcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 3: 3. Good health